Provided by Tiger Trade Technology Pte. Ltd.

VolitionRX

0.4169
-0.0275-6.19%
Post-market: 0.4100-0.0069-1.66%19:52 EDT
Volume:545.82K
Turnover:235.83K
Market Cap:5.69M
PE:-0.11
High:0.4500
Open:0.4400
Low:0.4101
Close:0.4444
52wk High:14.80
52wk Low:0.4101
Shares:13.65M
Float Shares:12.33M
Volume Ratio:0.80
T/O Rate:4.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8023
EPS(LYR):-4.3726
ROE:-730.06%
ROA:-142.94%
PB:-0.18
PE(LYR):-0.10

Loading ...

VolitionRX (VNRX) Receives a Buy from Maxim Group

TIPRANKS
·
Aug 18

VolitionRx Posts Corporate Deck Outlining Licensing-Led Strategy for Nu.Q Diagnostics in Cancer, Sepsis, Veterinary Testing

Reuters
·
Aug 14

VolitionRX Q2 EPS $(0.85) Misses $(0.57) Estimate, Sales $398.657K Miss $482.667K Estimate

Benzinga Earnings
·
Aug 14

VolitionRx Q2 FY26 Operating Loss Narrows 34% to $4.2 Million; Operating Expenses Fall 32% on Year

Reuters
·
Aug 14

VolitionRX Limited Announces Second Quarter 2026 Financial Results and Business Update

THOMSON REUTERS
·
Aug 14

VolitionRx Says Finger-Prick Sepsis Test Tracks Lab Nu.Q NETs Assay in Clinical Study

Reuters
·
Aug 12

VolitionRx Gelar Konferensi Kinerja Kuartal II 2026 Dan Pembaruan Bisnis

Reuters
·
Aug 12

VolitionRx Issues 779,371 Shares to Lind Global to Meet Convertible Note Obligations

Reuters
·
Aug 08

VolitionRx Publishes First Peer-Reviewed Paper on Capture-Seq Liquid Biopsy Technology

Reuters
·
Aug 05

Volitionrx - Advances Nu.Q Nets Platform Towards Commercialization

Reuters
·
Jul 30

VolitionRX - Advances Nu.q Nets Platform Towards Commercialization

THOMSON REUTERS
·
Jul 30

VolitionRx Publishes Nu.Q NETs Platform Update Presentation on Sepsis Biomarker Data

Reuters
·
Jul 30

Volitionrx Held Annual Shareholder Meeting; 4,261,161 Shares Represented by Proxy or in Person

Reuters
·
Jul 22

Volitionrx Posts Corporate Deck Outlining Nu.q Licensing Strategy Across Cancer, Sepsis and Veterinary Testing

Reuters
·
Jul 21

Analysts Have Conflicting Sentiments on These Healthcare Companies: Evolus (EOLS), Alkermes (ALKS) and VolitionRX (VNRX)

TIPRANKS
·
Jul 08

Volitionrx Announces Availability of New Press Release

Reuters
·
Jul 07

Volitionrx Announces Data Showing the Prognostic Value of Its Nu.q® Cancer Test

THOMSON REUTERS
·
Jul 07

VolitionRx issues 333,332 shares to Lind to satisfy $416,666 note payment obligation

Reuters
·
Jun 19

VolitionRX Price Target Announced at $4.00/Share by Maxim Group

Dow Jones
·
Jun 19

VolitionRx Collaborates With Japan's Sysmex for Optimization on Platform

MT Newswires Live
·
Jun 17